QMS Medical Allied Services Approves FY26 Results, Recommends Dividend, and Re-appoints Internal Auditor

QMS Medical Allied Services Approves FY26 Results, Recommends Dividend, and Re-appoints Internal Auditor

QMS Medical Allied Services Approves FY26 Results, Recommends Dividend, and Re-appoints Internal Auditor​

QMS Medical Allied Services Limited announced that its Board of Directors, in a meeting held on May 30, 2026, approved the company’s Standalone and Consolidated Audited Financial Results for the half year and financial year ended March 31, 2026.

The Board also recommended a final dividend of Rs. 0.50 per share, equating to a 5% dividend rate for the financial year 2025-2026, subject to approval by the shareholders at the upcoming Annual General Meeting.

Financial Results and Auditing Opinion​

The company's statutory auditors, H.H. Dedhia And Associates, issued an unmodified opinion on the Audited Standalone Financial Statements for the financial year ended March 31, 2026.

The Board also approved the comprehensive financial results, providing data for the period ended March 31, 2026, as well as comparative figures for the year ended March 31, 2025.

Key financial highlights for the period ending March 31, 2026, include:

Financial MetricStandalone (Year Ended 31.03.2026)Consolidated (Year Ended 31.03.2026)
Total Income (net)15,265.2017,392.96
Total Expenses14,319.9815,748.97
Profit Before Tax945.221,643.99
Profit for the Period669.081,191.68

The company's Balance Sheet data for the consolidated results shows total equity and liabilities reaching 21,284.85 Lakhs as of March 31, 2026, compared to 18,995.42 Lakhs in the previous year.

Corporate Governance and Operational Updates​

In an update regarding governance, the Board approved the re-appointment of M/s. Khushbu Parekh & Co., Chartered Accountants, as the Internal Auditors of the Company for the financial year 2026-2027.

Furthermore, the Board approved the Information Memorandum necessary for the company's migration from NSE Emerge to the Main Board on the NSE.

For the consolidated financial results, the Board of Directors of QMS Medical Allied Services Limited and its subsidiary, Saarthi Healthcare Private Limited, were responsible for the preparation and presentation of the results, giving a true and fair view of the Group's performance.

The company stated that it is operating as a single segment company, engaged in 'Healthcare Equipment/Supplies and Services', and therefore, no separate reportable business segment disclosure is applicable.

QMSMEDI Stock Price Movement​

On Friday, QMS Medical Allied Services Limited shares rallied, gaining 4.26% to close at ₹88.10, up ₹3.60 from the previous close. The stock settled at this level amid a solid volume of 14,000 shares traded.
 

Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.

The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.

Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.

Last edited by a moderator:
Back
Top